TriSalus Life Sciences, Which Is In The Midst Of Merging With MedTech Acquisition Corporation, Presented Additional Data For SD-101 Delivered Via The Exclusive PEDDT Method With The TriNav Device
Portfolio Pulse from Benzinga Newsdesk
TriSalus Life Sciences presented additional data for SD-101 delivered via the exclusive PEDDT method with the TriNav device, amid its merger with MedTech Acquisition Corporation (MTAC).
June 12, 2023 | 11:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MedTech Acquisition Corporation (MTAC) is merging with TriSalus Life Sciences, which presented additional data for its SD-101 treatment delivered via the TriNav device.
The additional data for SD-101 delivered via the TriNav device is a positive development for TriSalus Life Sciences. As MTAC is in the process of merging with TriSalus, this news is directly relevant and important for MTAC investors. The positive data may lead to increased interest in the merged company, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100